Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage

计划入组 320 人 · 首次发布于 2025 年 10 月 20 日

Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding

计划入组 208 人 · 首次发布于 2023 年 2 月 3 日

Fibrinogen in Liver Transplant

计划入组 60 人 · 首次发布于 2025 年 12 月 5 日

Fibrinogen human(Artiss, Evarrest, Evicel, Fibryga, Riastap, Tachosil, Tisseel, Vistaseal, TachoSil)

Rx

porcine-derived fibrinogen

BQ-Complex

INTERCEPT PHARMACEUTICALS, INC.

United States

INTERCEPT PHARMACEUTICALS INC

United States

HAYATABAD MEDICAL COMPLEX

Pakistan

Cerus Highlights INTERCEPT Blood System Advancements at AABB 2024

Cerus Corporation Secures $7.2M DoD Contract Amendment to Advance Trauma Hemorrhage Treatment

Pathogen-Reduced Cryoprecipitate Trial Aims to Improve Transfusion Outcomes in Cardiac Surgery